Schedule your first visit and labs → Schedule Online

Longevity Clinic BioIdentical Hormone Therapies – Bellevue

Longevity medical clinic

Estrogen References

  1. Estradiol improves cerebellar memory formation by activating estrogen receptor beta. Andreescu, C. E., B. A. Milojkovic, et al. 2007. J Neurosci 27(40): 10832-9.
  2. Effects of estrogen and progesterone on spatial memory consolidation in aged females. Harburger, L. L., J. C. Bennett, et al. 2007. Neurobiol Aging 28(4): 602-10.
  3. Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Morgan, M. L., I. A. Cook, et al. 2007. Maturitas 56(1): 54-60.
  4. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. Rapp, S. R., M. A. Espeland, et al. 2003. JAMA 289(20): 2663-72.
  5. Depression, the perimenopause, and estrogen therapy. Schmidt, P. J. 2005. Ann N Y Acad Sci 1052: 27-40.
  6. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Shaywitz, S. E., F. Naftolin, et al. 2003. Menopause 10(5): 420-6.
  7. Depression, estrogen, and the Women’s Health Initiative. Stewart, D. E., D. E. Rolfe, et al. 2004. Psychosomatics 45(5): 445-7.
  8. Comparative measurements of serum estriol, estradiol, and estrone in non-pregnant, premenopausal women; a preliminary investigation. Wright, J. V., B. Schliesman, et al. 1999. Altern Med Rev 4(4): 266-70.
  9. Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells.Fukui, M. and B. T. Zhu. 2009. Mol Carcinog 48(1): 66-78.
  10. Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.James, J., D. J. Murry, et al. 2007. Invest New Drugs 25(1): 41-8.
  11. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. Liu, Z. J. and B. T. Zhu. 2004. J Steroid Biochem Mol Biol 88(3): 265-75.
  12. The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells. Newman, S. P., C. R. Ireson, et al. 2006. Cancer Res 66(1): 324-30.

Growth Hormone References

  1. Effects of Growth Hormone-Releasing Hormone on Cognitive Function in Adults With Mild Cognitive Impairment and Healthy Older Adults: Results of a Controlled Trial. Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, Vitiello MV. Arch Neurol. 2012 Aug 6:1-10. doi: 10.1001/archneurol.2012.1970. [Epub ahead of print]
  2. Cognitive function in association with sex hormones in postmenopausal women. Kocoska-Maras L, Rådestad AF, Carlström K, Bäckström T, Schoultz BV, Hirschberg AL. Gynecol Endocrinol. 2012 Sep 11. [Epub ahead of print]
  3. Association of IGF-I and IGFBP-3 with health care costs and hospitalization: results from a prospective observational study. Baumeister SE, Friedrich N, Schmidt CO, Völzke H, Nauck M, Hoffmann W, Flessa S, Marschall P, Wallaschofski H. Growth Horm IGF Res. 2011 Apr;21(2):89-95. Epub 2011 Mar 9.

Progesterone References

  1. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. Caufriez A, Leproult R, L’Hermite-Balériaux M, Kerkhofs M, Copinschi G. J Clin Endocrinol Metab. 2011 Apr;96(4):E614-23. Epub 2011 Feb 2.

Testosterone References

  1. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. Hankinson, S. E. and A. H. Eliassen. 2007. J Steroid Biochem Mol Biol 106(1-5): 24-30.
  2. Treating low sexual desire – new findings for testosterone in women. Heiman, J. R. 2008. N Engl J Med 359(19): 2047-9.
  3. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. Heufelder, A. E., F. Saad, et al. 2009. J Androl 30(6): 726-33.
  4. Testosterone may cause breast cancer. Howard, J. M. 2005. Int J Cancer 115(3): 497; author reply 498.
  5. Testosterone for low libido in postmenopausal women not using systemic oestrogen therapy. Davis, S. R. 2009. Med J Aust 191(3): 134-5.
  6. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Davis, S. R., P. McCloud, et al. 1995. Maturitas 21(3): 227-36.
  7. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Davis, S. R., P. McCloud, et al. 2008. Maturitas 61(1-2): 17-26.
  8. Testosterone for low libido in postmenopausal women not taking estrogen. Davis, S. R., M. Moreau, et al. 2008. N Engl J Med 359(19): 2005-17.
  9. The incidence of invasive breast cancer among women prescribed testosterone for low libido. Davis, S. R., R. Wolfe, et al. 2009. J Sex Med 6(7): 1850-6.
  10. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Dimitrakakis, C., R. A. Jones, et al. 2004. Menopause 11(5): 531-5.
  11. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society.” 2005. Menopause 12(5): 496-511; quiz 649.
  12. Testosterone supplementation for hypoactive sexual desire disorder in women. Woodis CB, McLendon AN, Muzyk AJ. Pharmacotherapy. 2012 Jan;32(1):38-53. doi: 10.1002/PHAR.1004.
  13. Low-dose transdermal testosterone augmentation therapy improves depression severity in women. Miller, K. K., R. H. Perlis, et al. 2009. CNS Spectr 14(12): 688-94.

Pages: 1 2